Cargando…
Exploring the OncoGenomic Landscape of cancer
BACKGROUND: The widespread incorporation of next-generation sequencing into clinical oncology has yielded an unprecedented amount of molecular data from thousands of patients. A main current challenge is to find out reliable ways to extrapolate results from one group of patients to another and to br...
Autores principales: | Mateo, Lidia, Guitart-Pla, Oriol, Duran-Frigola, Miquel, Aloy, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090738/ https://www.ncbi.nlm.nih.gov/pubmed/30071882 http://dx.doi.org/10.1186/s13073-018-0571-0 |
Ejemplares similares
-
A PanorOmic view of personal cancer genomes
por: Mateo, Lidia, et al.
Publicado: (2017) -
Encircling the regions of the pharmacogenomic landscape that determine drug response
por: Fernández-Torras, Adrià, et al.
Publicado: (2019) -
Rational design of cancer gene panels with OncoPaD
por: Rubio-Perez, Carlota, et al.
Publicado: (2016) -
Recycling side-effects into clinical markers for drug repositioning
por: Duran-Frigola, Miquel, et al.
Publicado: (2012) -
Drug sensitivity in cancer cell lines is not tissue-specific
por: Jaeger, Samira, et al.
Publicado: (2015)